Listen to this chapter in the podcast from the beginning to learn more about full episode.

Fewer COVID Vaccine Doses Materialized Last Fall Than The U.S. Government Hoped - Short Wave | Transcription & Insights

Description

Manufacturers can expect to face unforeseen hurdles when they begin to mass-produce a brand new pharmaceutical product, and in a pandemic, there are bound to be supply chain problems as well. But in late 2020, Pfizer was delivering fewer doses than the government expected and then-federal officials told NPR they did not know why.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Audio